225 related articles for article (PubMed ID: 1245783)
21. Activated reptilase clot retraction of dog platelet-rich plasma: differences with human platelet-rich plasma.
De Clerck F; Verheyen A; Vermylen J; Reneman R
Scand J Haematol; 1975 Dec; 15(5):347-58. PubMed ID: 1202624
[TBL] [Abstract][Full Text] [Related]
22. Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation.
Bottecchia D; Fantin G; Doni MG
Scand J Haematol; 1984 Jan; 32(1):33-40. PubMed ID: 6695148
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D.
Sugidachi A; Ogawa T; Asai F; Saito S; Ozaki H; Fusetani N; Karaki H; Koike H
Thromb Haemost; 1998 Mar; 79(3):614-9. PubMed ID: 9531051
[TBL] [Abstract][Full Text] [Related]
24. Essential athrombia: study of a new case.
Inceman S; Tangün Y
Thromb Diath Haemorrh; 1975 Apr; 33(2):278-85. PubMed ID: 1138423
[TBL] [Abstract][Full Text] [Related]
25. Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro.
Kawase T; Okuda K; Wolff LF; Yoshie H
J Periodontol; 2003 Jun; 74(6):858-64. PubMed ID: 12886997
[TBL] [Abstract][Full Text] [Related]
26. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts.
Kasahara K; Kaneda M; Miki T; Iida K; Sekino-Suzuki N; Kawashima I; Suzuki H; Shimonaka M; Arai M; Ohno-Iwashita Y; Kojima S; Abe M; Kobayashi T; Okazaki T; Souri M; Ichinose A; Yamamoto N
Blood; 2013 Nov; 122(19):3340-8. PubMed ID: 24002447
[TBL] [Abstract][Full Text] [Related]
27. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
[TBL] [Abstract][Full Text] [Related]
28. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity.
Jennings LK; White MM; Mandrell TD
Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236
[TBL] [Abstract][Full Text] [Related]
29. Quantification and optimization of clot retraction in washed human platelets by Sonoclot coagulation analysis.
Yadav P; Beura SK; Panigrahi AR; Singh SK
Int J Lab Hematol; 2022 Feb; 44(1):177-185. PubMed ID: 34609044
[TBL] [Abstract][Full Text] [Related]
30. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
[TBL] [Abstract][Full Text] [Related]
32. Clinically relevant HOCl concentrations reduce clot retraction rate via the inhibition of energy production in platelet mitochondria.
Misztal T; Rusak T; Tomasiak M
Free Radic Res; 2014 Dec; 48(12):1443-53. PubMed ID: 25236568
[TBL] [Abstract][Full Text] [Related]
33. The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation.
Hudák R; Vincze J; Csernoch L; Beke Debreceni I; Oláh T; Erdődi F; Clemetson KJ; Kappelmayer J
Biomed Res Int; 2017; 2017():9795271. PubMed ID: 28680886
[TBL] [Abstract][Full Text] [Related]
34. Aggregation of platelets and inert particles induced by thrombin.
Chao FC; Tullis JL; Conneely GS; Lawler JW
Thromb Haemost; 1976 Jun; 35(3):717-36. PubMed ID: 10638
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructure of the interaction between human platelets and polymerizing fibrin within the first minutes of clot formation.
Morgenstern E; Ruf A; Patscheke H
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):543-6. PubMed ID: 2133232
[TBL] [Abstract][Full Text] [Related]
36. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
37. A novel, quantitative clot retraction assay to evaluate platelet function.
Muraoka WT; Nair PM; Darlington DN; Wu X; Bynum JA; Cap AP
Platelets; 2023 Dec; 34(1):2254403. PubMed ID: 37700390
[TBL] [Abstract][Full Text] [Related]
38. Aggregation of washed platelets from non-anticoagulated human blood is not reversible.
Bowry SK; Müller-Berghaus G
Thromb Haemost; 1986 Oct; 56(2):172-7. PubMed ID: 3101220
[TBL] [Abstract][Full Text] [Related]
39. Estriol-induced fibrinolysis due to the activation of plasminogen to plasmin by nitric oxide synthesis in platelets.
Jana P; Maiti S; Kahn NN; Sinha AK
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):316-23. PubMed ID: 24695088
[TBL] [Abstract][Full Text] [Related]
40. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
